A Phase 1 Randomized, Double-Blinded, Placebo-Controlled Rectal Safety and Acceptability Study of Tenofovir 1% Gel
Phase of Trial: Phase I
Latest Information Update: 08 Dec 2015
At a glance
- Drugs Tenofovir (Primary) ; Nonoxinol 9
- Indications HIV-1 infections
- Focus Adverse reactions
- Acronyms Project-Gel
- Sponsors CONRAD
- 21 Aug 2012 Actual end date (Jul 2011) added as reported by ClinicalTrials.gov.
- 08 Mar 2012 Results presented at the 19th Conference on Retroviruses and Opportunistic Infections.
- 12 Nov 2010 New trial record